• Medical_Professionals
• Medical_students
• Nurses

With the US in the midst of an opioid crisis, it has never been more critical for the pharmaceutical, biotechnology and academic fields to unite in a common goal to innovate and accelerate the discovery and development of novel non-opioid therapies to treat pain.

This summit and its expert speaker faculty will update you on the latest and novel R&D efforts currently ongoing in discovery and optimization of non-opioid analgesic targets and their mechanism of action. In addition, the inaugural Non-Opioid Pain Drug Development Summit will be your dedicated platform to overcome translational challenges such as animal model predictive value, biomarker identification, and proving efficacy against placebo effect. So join our platform to understand the science and also critical decision making processes that are crucial to successful non-opioid pain drug development.

Non-Addictive Opioid Based Therapeutics as a Catalyst for Better Pain R&D–  The challenge facing drug developers in pain drug R&D is twofold: developing new alternatives that are effective in pain management while minimizing the euphoric side effects. At our summit, find out how the latest development in non-addictive opioid pain drug development could pave your approach towards developing novel non-opioid pain drugs

Optimizing the Validation of Novel Non-Opioid Analgesic Targets- Understanding the complex underlying mechanism of action and discovering novel analgesic targets are key to successfully develop alternative pain therapies. At our summit, find out the most cutting edge areas of pain research in pursuit of novel target identification and validation – beyond traditional opioid receptors

Overcoming Key Translational Hurdles- Well-designed clinical studies to demonstrate safety and significant efficacy above and beyond placebo controls and existing pain treatments is critical to reduce failure rates. At our summit hear about and delve into discussions around development of robust pain models and clinical validation & predictively of biomarkers for optimized patient selection, recruitment and adherence

Successful Clinical Development of Non-Opioid Pain Drugs- The long term goal of the most of the drug developers is to develop new alternatives for pain relief that are non-addictive and non-opioid based. At our summit, through case studies and networking opportunities, widen your company’ horizon by establishing new clinical trial networks and contacts to accelerate drug development for patients with high unmet needs for pain management

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Non-Opioid Pain Drug Development Summit will be held at:

Wyndham Boston Beacon Hill

5 Blossom St

Boston, MA

02114, USA

Submission Info

T: +44 (0)20 3141 8700

E: info@hansonwade.com

T: +44 (0)20 3141 8700

E: info@hansonwade.com